Expression of the intracellular type amastigote particular genes within the Leishmania donovani parasite performs a serious position in parasite replication within the macrophage. Within the present work, we’ve characterised a novel hypothetical gene, Ld30b that’s particularly transcribed within the intracellular stage of the parasite. The recombinant Ld30b protein exists as a pentamer in answer as recognized by native-PAGE and measurement exclusion gel chromatography.
Structural evaluation utilizing round dichroism and molecular modeling point out that Ld30b belongs to household of cAMP-dependent protein kinase sort I-alpha regulatory subunit. Co-localization immunofluorescence microscopy and western blot analyses (utilizing anti-Ld30b antibody and anti-hypoxanthine-guanine phosphoribosyl transferase, a glycosome marker) on the remoted parasite glycosome organelle fractions present that Ld30b is localized in glycosome, although lacked a glycosome focusing on PTS1/2 sign within the protein sequence.
Episomal expression of Ld30b within the parasite precipitated the arrest of promastigotes and amastigotes progress in vitro. Cell cycle evaluation utilizing movement cytometry signifies that these parasites are arrested in ‘sub G0/G1’ section of the cell cycle. Single allele knockout of Ld30b within the parasite equally attenuated its progress by accumulation of cells within the S section of cell cycle, thus confirming the possible significance of acceptable stage of protein within the cells. Finding out such intracellular stage expressing genes may unravel novel regulatory pathways for the event of medicine or vaccine candidates towards leishmaniasis.
A big-scale expression technique for multimeric extracellular protein complexes utilizing Drosophila S2 cells and its software to the recombinant expression of heterodimeric ligand-binding domains of style receptor.
Most of the extracellular proteins or extracellular domains of plasma membrane proteins exist or operate as homo- or heteromeric multimer protein complexes. Profitable recombinant manufacturing of such proteins is usually achieved by co-expression of the parts utilizing eukaryotic cells by way of the secretory pathway. Right here we report a method addressing large-scale expression of hetero-multimeric extracellular domains of plasma membrane proteins and its software to the extracellular domains of a style receptor.
The goal receptor consists of a heterodimer of T1r2 and T1r3 proteins, and their extracellular ligand binding domains (LBDs) are accountable for the notion of main style substances. Nonetheless, regardless of the useful significance, recombinant manufacturing of the heterodimeric proteins has to this point been unsuccessful. We achieved the profitable preparation of the heterodimeric LBD by use of Drosophila S2 cells, which have a excessive secretory capability, and by the institution of a secure high-expression clone producing each subunits at a comparable stage.
The strategy overcame the issues encountered within the typical transient expression of the receptor protein in insect cells utilizing baculovirus or vector lipofection, which failed within the correct heterodimer manufacturing due to the biased expression of T1r3LBD over T1r2LBD. The big-scale expression methodology reported right here might function one of many appreciable methods for the preparation of multimeric extracellular protein complexes.
Fourier Remodel-Ion Cyclotron Resonance Mass Spectrometry as a Platform for Characterizing Multimeric Membrane Protein Complexes.
Membrane protein characterization is constantly hampered by challenges with expression, purification, and solubilization. Amongst a number of biophysical strategies employed for his or her characterization, native-mass spectrometry (MS) has emerged as a strong software for the evaluation of membrane proteins and complexes. Right here, two MS platforms, the FT-ICR and Q-ToF, have been explored to research the homotetrameric water channel protein, AquaporinZ (AqpZ), beneath non-denaturing circumstances.
This 97 kDa membrane protein advanced will be readily liberated from the octylglucoside (OG) detergent micelle beneath a variety of instrument circumstances on each MS platforms. Growing the utilized collision power of the FT-ICR collision cell yielded various levels of tetramer (97 kDa) liberation from the OG micelles, in addition to dissociation into the trimeric (72 kDa) and monomeric (24 kDa) substituents.
Tandem-MS on the Q-ToF yielded increased depth tetramer sign and, relying on the m/z area chosen, the noticed monomer sign assorted in depth. Precursor ion collection of an m/z vary above the anticipated protein sign distribution, adopted by gentle collisional activation, is ready to effectively liberate AqpZ with a excessive S/N ratio. The tetrameric cost state distribution obtained on each devices demonstrated superpositioning of a number of proteoforms because of various levels of N-terminal formylation. Graphical Summary ᅟ
The most important outer sheath protein kinds distinct conformers and multimeric complexes within the outer membrane and periplasm of Treponema denticola.
The most important outer sheath protein (MOSP) is a outstanding constituent of the cell envelope of Treponema denticola (TDE) and one in every of its principal virulence determinants. Bioinformatics predicts that MOSP consists of N- and C-terminal domains, MOSPN and MOSPC. Biophysical evaluation of constructs refolded in vitro demonstrated that MOSPC, beforehand proven to own porin exercise, kinds amphiphilic trimers, whereas MOSPN kinds an prolonged hydrophilic monomer.
In TDE and E. coli expressing MOSP with a PelB sign sequence (PelB-MOSP), MOSPC is OM-embedded and surface-exposed, whereas MOSPN resides within the periplasm. Immunofluorescence assay, floor proteolysis, and novel cell fractionation schemes revealed that MOSP in TDE exists as outer membrane (OM) and periplasmic trimeric conformers; PelB-MOSP, in distinction, fashioned solely OM-MOSP trimers.
Though each conformers type hetero-oligomeric complexes in TDE, solely OM-MOSP associates with dentilisin. Mass spectrometry (MS) indicated that OM-MOSP interacts with proteins along with dentilisin, most notably, oligopeptide-binding proteins (OBPs) and the β-barrel of BamA. MS additionally recognized candidate companions for periplasmic MOSP, together with TDE1658, a spirochete-specific SurA/PrsA ortholog.
Active Recombinant Human NQO1 Protein |
|||
| NQO1-001H | Creative BioMart | 1mg | EUR 3200 |
|
Description: 2-8 centigrade |
|||
MOUSE ANTI HUMAN NQO1 |
|||
| MBS219386-01mg | MyBiosource | 0.1mg | EUR 365 |
MOUSE ANTI HUMAN NQO1 |
|||
| MBS219386-5x01mg | MyBiosource | 5x0.1mg | EUR 1465 |
NQO1 Protein, Human, Recombinant (His Tag) |
|||
| MBS8121065-005mg | MyBiosource | 0.05mg | EUR 395 |
NQO1 Protein, Human, Recombinant (His Tag) |
|||
| MBS8121065-5x005mg | MyBiosource | 5x0.05mg | EUR 1635 |
NQO1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV104988 | ABM | 500 ng | EUR 394.8 |
Recombinant Human NQO1 Protein, His, E.coli-1mg |
|||
| QP12875-1mg | EnQuireBio | 1mg | EUR 6301.2 |
Recombinant Human NQO1 Protein, His, E.coli-2ug |
|||
| QP12875-2ug | EnQuireBio | 2ug | EUR 186 |
NQO1 Protein Vector (Human) (pPB-C-His) |
|||
| PV104986 | ABM | 500 ng | EUR 394.8 |
NQO1 Protein Vector (Human) (pPB-N-His) |
|||
| PV104987 | ABM | 500 ng | EUR 394.8 |
NQO1 Protein Vector (Human) (pPM-C-His) |
|||
| PV104989 | ABM | 500 ng | EUR 394.8 |
Recombinant Human NQO1 Protein, His, E.coli-10ug |
|||
| QP12875-10ug | EnQuireBio | 10ug | EUR 241.2 |
Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| 20-abx167110 | Abbexa |
|
|
Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| abx167110-100g | Abbexa | 100 µg | EUR 587.5 |
Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| abx167110-10g | Abbexa | 10 µg | EUR 225 |
Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| abx167110-50g | Abbexa | 50 µg | EUR 400 |
Recombinant Human NQO1 Protein, His (Fc)-Avi-tagged |
|||
| NQO1-1534H | Creative BioMart | 50ug | EUR 2398.4 |
|
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
|||
Human NQO1 Antibody |
|||
| 32959-05111 | AssayPro | 150 ug | EUR 215 |
Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein |
|||
| abx073766-100tests | Abbexa | 100 tests | EUR 225 |
Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein |
|||
| abx073766-1920tests | Abbexa | 1920 tests | EUR 6575 |
Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein |
|||
| abx073766-400tests | Abbexa | 400 tests | EUR 325 |
Recombinant Human NQO1/DT-diaphorase Protein (His Tag) |
|||
| PKSH030925-50ug | Elabscience Biotech | 50ug | EUR 867 |
|
Description: Human |
|||
Recombinant Human NQO1 / DT-diaphorase Protein (His tag) |
|||
| MBS2545593-005mg | MyBiosource | 0.05mg | EUR 805 |
Recombinant Human NQO1 / DT-diaphorase Protein (His tag) |
|||
| MBS2545593-5x005mg | MyBiosource | 5x0.05mg | EUR 3610 |
NQO1 protein (His tag) |
|||
| 80R-1197 | Fitzgerald | 100 ug | EUR 622 |
|
Description: Purified recombinant Human NQO1 protein |
|||
OPPA02018-2UG - NQO1 Protein |
|||
| OPPA02018-2UG | Aviva Systems Biology | 2ug | EUR 70 |
NQO1 siRNA (Human) |
|||
| MBS8231363-15nmol | MyBiosource | 15nmol | EUR 405 |
NQO1 siRNA (Human) |
|||
| MBS8231363-30nmol | MyBiosource | 30nmol | EUR 565 |
NQO1 siRNA (Human) |
|||
| MBS8231363-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
Rabbit Anti Human NQO1 Monoclonal Clone AAOB-14 |
|||
| IRBAHUNQO1AAOB14C100UL | Innovative research | each | EUR 496 |
|
Description: Rabbit Anti Human NQO1 Monoclonal Clone AAOB-14 |
|||
Recombinant Human NQO1 |
|||
| MBS7613006-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human NQO1 |
|||
| MBS7613006-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human NQO1 |
|||
| MBS7613006-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human NQO1 |
|||
| MBS7613006-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
anti- NQO1 antibody |
|||
| FNab05830 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against NQO1 |
|||
NQO1, human recombinant |
|||
| 7571-10 | Biovision | each | EUR 392.4 |
NQO1, human recombinant |
|||
| 7571-50 | Biovision | each | EUR 1123.2 |
NQO1 Recombinant Protein (Rat) |
|||
| RP214418 | ABM | 100 ug | Ask for price |
NQO1 Recombinant Protein (Mouse) |
|||
| RP154820 | ABM | 100 ug | Ask for price |
OCOA17845-20UG - NQO1 Protein Lysate |
|||
| OCOA17845-20UG | Aviva Systems Biology | 20ug | EUR 169 |
OCOA16065-20UG - NQO1 Protein Lysate |
|||
| OCOA16065-20UG | Aviva Systems Biology | 20ug | EUR 169 |
OCOA00288-20UG - NQO1 Protein Lysate |
|||
| OCOA00288-20UG | Aviva Systems Biology | 20ug | EUR 169 |
Mouse Monoclonal anti-human NQO1 |
|||
| hAP-0641 | Angio Proteomie | 50ug | EUR 400 |
NQO1 NAD(P)H Dehydrogenase Quinone 1 Human Recombinant Protein |
|||
| PROTP15559 | BosterBio | Regular: 10ug | EUR 380.4 |
|
Description: NQO1 Human Recombinant fused with a 20 amino acids His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 294 amino acids (1-274 a.a.) and having a molecular mass of 33kDa.;The NQO1 is purified by proprietary chromatographic techniques. |
|||
Human NQO1 ELISA Kit |
|||
| ELA-E2154h | Nova Lifetech | 96tests | EUR 696 |
Human NQO1 ELISA KIT |
|||
| EF006205 | Nova Lifetech | 96tests | EUR 566 |
Human, Rat, Mouse NQO1 antibody |
|||
| P0043 | Omnimabs | 100ul | EUR 150 |
Human, Rat, Mouse NQO1 antibody |
|||
| P0996 | Omnimabs | 100ul | EUR 150 |
Human NQO1 Antibody (Biotin Conjugate) |
|||
| 32959-05121 | AssayPro | 150 ug | EUR 315 |
Human NQO1 shRNA Plasmid |
|||
| 20-abx951197 | Abbexa |
|
|
OPCA03267-20UG - Nqo1 Recombinant Protein |
|||
| OPCA03267-20UG | Aviva Systems Biology | 20ug | EUR 379 |
OPCD05779-10UG - NQO1 Recombinant Protein |
|||
| OPCD05779-10UG | Aviva Systems Biology | 10ug | EUR 149 |
OPCD05779-50UG - NQO1 Recombinant Protein |
|||
| OPCD05779-50UG | Aviva Systems Biology | 50ug | EUR 369 |
OPCD05780-10UG - NQO1 Recombinant Protein |
|||
| OPCD05780-10UG | Aviva Systems Biology | 10ug | EUR 149 |
OPCD05780-50UG - NQO1 Recombinant Protein |
|||
| OPCD05780-50UG | Aviva Systems Biology | 50ug | EUR 379 |
OPCD05781-10UG - NQO1 Recombinant Protein |
|||
| OPCD05781-10UG | Aviva Systems Biology | 10ug | EUR 139 |
OPCD05781-50UG - NQO1 Recombinant Protein |
|||
| OPCD05781-50UG | Aviva Systems Biology | 50ug | EUR 349 |
OPCA03267-100UG - Nqo1 Recombinant Protein |
|||
| OPCA03267-100UG | Aviva Systems Biology | 100ug | EUR 555 |
OPCA03267-500UG - Nqo1 Recombinant Protein |
|||
| OPCA03267-500UG | Aviva Systems Biology | 500ug | EUR 1534 |
OPCD05779-200UG - NQO1 Recombinant Protein |
|||
| OPCD05779-200UG | Aviva Systems Biology | 200ug | EUR 729 |
OPCD05780-200UG - NQO1 Recombinant Protein |
|||
| OPCD05780-200UG | Aviva Systems Biology | 200ug | EUR 749 |
OPCD05781-200UG - NQO1 Recombinant Protein |
|||
| OPCD05781-200UG | Aviva Systems Biology | 200ug | EUR 699 |
NQO1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV285896 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV285894 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV285895 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV285897 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV206432 | ABM | 500 ng | EUR 723.6 |
Human NQO1 knockout cell line |
|||
| ABC-KH10291 | AcceGen | 1 vial | Ask for price |
|
Description: Human NQO1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
NQO1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV206430 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV206431 | ABM | 500 ng | EUR 723.6 |
NQO1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV206433 | ABM | 500 ng | EUR 723.6 |
Human NQO1 knockdown cell line |
|||
| ABC-KD10291 | AcceGen | 1 vial | Ask for price |
|
Description: Human NQO1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
NQO1 ORF Vector (Human) (pORF) |
|||
| ORF026247 | ABM | 1.0 ug DNA | EUR 114 |
NQO1 (NM_000903) Human Over-expression Lysate |
|||
| LS001728 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 1 |
|||
Recombinant Human NQO1, GST-tagged |
|||
| NQO1-1352H | Creative BioMart | 25ug | EUR 255.2 |
|
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles. |
|||
Rat NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| 20-abx650803 | Abbexa |
|
|
Rat NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| abx650803-5mg | Abbexa | 5 mg | EUR 412.5 |
NQO1 ELISA Kit (Human) (OKCD09345) |
|||
| OKCD09345 | Aviva Systems Biology | 96 Wells | EUR 1090.8 |
|
Description: Description of target: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.122ng/mL |
|||
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| 20-abx168462 | Abbexa |
|
|
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|||
| abx168462-1ml | Abbexa | 1 ml | EUR 237.5 |
NQO1 (human intracellular) ELISA Kit |
|||
| GWB-AXR261 | GenWay Biotech | 100 assays | Ask for price |
NQO1 (human intracellular) ELISA Kit |
|||
| K4926-100 | Biovision | each | EUR 1149.6 |
Human Intracellular NQO1 ELISA Kit |
|||
| LF-EK70031 | Abfrontier | 1×96T | EUR 722.4 |
Human NQO1 AssayLite™ Antibody (RPE Conjugate) |
|||
| 32959-05151 | AssayPro | 150 ug | EUR 370 |
Human NQO1 AssayLite™ Antibody (APC Conjugate) |
|||
| 32959-05161 | AssayPro | 150 ug | EUR 370 |
Human NQO1 AssayLite™ Antibody (FITC Conjugate) |
|||
| 32959-05141 | AssayPro | 150 ug | EUR 370 |
Human NQO1 AssayLite™ Antibody (PerCP Conjugate) |
|||
| 32959-05171 | AssayPro | 150 ug | EUR 410 |
Recombinant Rat NQO1 Protein, His (Fc)-Avi-tagged |
|||
| NQO1-3717R | Creative BioMart | 50ug | EUR 2398.4 |
|
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
|||
NQO1 (untagged) - Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 4 |
|||
| SC334423 | Origene Technologies GmbH | 10 µg | Ask for price |
NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 1 |
|||
| SC119599 | Origene Technologies GmbH | 10 µg | Ask for price |
NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 2 |
|||
| SC302402 | Origene Technologies GmbH | 10 µg | Ask for price |
NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 3 |
|||
| SC302403 | Origene Technologies GmbH | 10 µg | Ask for price |
NQO1, 1-274aa, Human, His tag, E Coli |
|||
| MBS203393-002mg | MyBiosource | 0.02mg | EUR 275 |
NQO1, 1-274aa, Human, His tag, E Coli |
|||
| MBS203393-01mg | MyBiosource | 0.1mg | EUR 550 |
NQO1, 1-274aa, Human, His tag, E Coli |
|||
| MBS203393-05mg | MyBiosource | 0.5mg | EUR 1410 |
NQO1, 1-274aa, Human, His tag, E Coli |
|||
| MBS203393-5x05mg | MyBiosource | 5x0.5mg | EUR 6110 |
OKEH01528-96W - NQO1 ELISA Kit (Human) |
|||
| OKEH01528-96W | Aviva Systems Biology | 96Wells | EUR 525 |
OKCD09345-96W - NQO1 ELISA Kit (Human) |
|||
| OKCD09345-96W | Aviva Systems Biology | 96Wells | EUR 750 |
NQO1 antibody |
|||
| 22937 | SAB | 100ul | EUR 479 |
NQO1 antibody |
|||
| 22937-100ul | SAB | 100ul | EUR 468 |
NQO1 Antibody |
|||
| 32295 | SAB | 100ul | EUR 439 |
NQO1 Antibody |
|||
| 32295-100ul | SAB | 100ul | EUR 302.4 |
NQO1 Antibody |
|||
| 31283 | SAB | 100ul | EUR 319 |
NQO1 Antibody |
|||
| 31283-100ul | SAB | 100ul | EUR 302.4 |
NQO1 Antibody |
|||
| 31283-50ul | SAB | 50ul | EUR 224.4 |
NQO1 Antibody |
|||
| 3639-100 | Biovision | each | EUR 418.8 |
NQO1 Antibody |
|||
| 3639-30T | Biovision | each | EUR 175.2 |
NQO1 Antibody |
|||
| 35365 | SAB | 100ul | EUR 479 |
NQO1 Antibody |
|||
| 35365-100ul | SAB | 100ul | EUR 468 |
NQO1 Antibody |
|||
| 49364 | SAB | 100ul | EUR 499 |
NQO1 Antibody |
|||
| 49364-100ul | SAB | 100ul | EUR 399.6 |
NQO1 Antibody |
|||
| 49364-50ul | SAB | 50ul | EUR 286.8 |
NQO1 Antibody |
|||
| E031283 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
NQO1 Antibody |
|||
| 1-CSB-PA890070 | Cusabio |
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:10000, WB:1:500-1:2000, IHC:1:50-1:200 |
|||
NQO1 Antibody |
|||
| 1-CSB-PA016039GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
NQO1 Antibody |
|||
| 1-CSB-PA016039LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
NQO1 Antibody |
|||
| DF6437 | Affbiotech | 200ul | EUR 420 |
NQO1 Antibody |
|||
| DF6437-100ul | Affinity Biosciences | 100ul | EUR 280 |
NQO1 Antibody |
|||
| DF6437-200ul | Affinity Biosciences | 200ul | EUR 350 |
NQO1 Antibody |
|||
| E91518 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
NQO1 Antibody |
|||
| E38PA1342 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
NQO1 Antibody |
|||
| E314247 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
NQO1 antibody |
|||
| 70R-12504 | Fitzgerald | 100 ul | EUR 550 |
|
Description: Affinity purified Rabbit polyclonal NQO1 antibody |
|||
NQO1 antibody |
|||
| 70R-10256 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Affinity purified rabbit polyclonal NQO1 antibody |
|||
NQO1 antibody |
|||
| 70R-10257 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Affinity purified rabbit polyclonal NQO1 antibody |
|||
NQO1 antibody |
|||
| 70R-18946 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal NQO1 antibody |
|||
NQO1 antibody |
|||
| 70R-49661 | Fitzgerald | 100 ul | EUR 242 |
|
Description: Purified Polyclonal NQO1 antibody |
|||
NQO1 Antibody |
|||
| 1-CSB-PA003475 | Cusabio |
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
|||
NQO1 Antibody |
|||
| 1-CSB-PA102829 | Cusabio |
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
NQO1 Antibody |
|||
| ABD6437 | Nova Lifetech | 100ug | EUR 325 |
NQO1 Antibody |
|||
| F50335-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: NQO1 is a member of the NAD(P)H dehydrogenase(quinone) family and a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Altered expression of the protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). |
|||
NQO1 Antibody |
|||
| F50335-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: NQO1 is a member of the NAD(P)H dehydrogenase(quinone) family and a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Altered expression of the protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). |
|||
NQO1 Antibody |
|||
| GWB-MW183C | GenWay Biotech | 50ug | Ask for price |
NQO1 Antibody |
|||
| GWB-MW184D | GenWay Biotech | 50ug | Ask for price |
NQO1 Antibody |
|||
| GWB-E9E683 | GenWay Biotech | 0.1 mg | Ask for price |
NQO1 Antibody |
|||
| N1103-100UG | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: NAD(P)H:quinone oxidoreductase is an enzyme that catalyzes the two-electron reduction of quinones to hydroquinones, resulting in the activation or deactivation of the hydroquinone. Increased expression of NQO1 is seen in tumors of the breast, liver and colon and NSCLC (non-small cell lung cancer), suggesting a role in tumor development and possibly treatment. NQO1 has also been linked to Alzheimer's disease, found to be upregulated in response to the oxidative stress of the AD process. |
|||
NQO1 Antibody |
|||
| N1103-25UG | NSJ Bioreagents | 25 ug | EUR 177.65 |
|
Description: NAD(P)H:quinone oxidoreductase is an enzyme that catalyzes the two-electron reduction of quinones to hydroquinones, resulting in the activation or deactivation of the hydroquinone. Increased expression of NQO1 is seen in tumors of the breast, liver and colon and NSCLC (non-small cell lung cancer), suggesting a role in tumor development and possibly treatment. NQO1 has also been linked to Alzheimer's disease, found to be upregulated in response to the oxidative stress of the AD process. |
|||
NQO1 Antibody |
|||
| R35927-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: NAD(P)H dehydrogenase, quinone 1 |
|||
NQO1 Antibody |
|||
| R33500-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: NAD(P)H dehydrogenase, quinone 1 |
|||
NQO1 Antibody |
|||
| R31977 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. And this FAD-binding protein forms homodimers and reduces quinones to hydroquinones. In addition, this protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. |
|||
NQO1 Antibody |
|||
| RQ5489 | NSJ Bioreagents | 100 ul | EUR 356.15 |
|
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [RefSeq] |
|||
NQO1 Antibody |
|||
| MBS7128058-005mL | MyBiosource | 0.05mL | EUR 190 |
NQO1 Antibody |
|||
| MBS7128058-01mL | MyBiosource | 0.1mL | EUR 270 |
NQO1 Antibody |
|||
| MBS7128058-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
NQO1 Antibody |
|||
| MBS7128059-005mL | MyBiosource | 0.05mL | EUR 190 |
NQO1 Antibody |
|||
| MBS7128059-01mL | MyBiosource | 0.1mL | EUR 270 |
NQO1 Antibody |
|||
| MBS7128059-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
NQO1 Antibody |
|||
| MBS7052193-005mg | MyBiosource | 0.05mg | EUR 190 |
NQO1 Antibody |
|||
| MBS7052193-01mg | MyBiosource | 0.1mg | EUR 270 |
NQO1 Antibody |
|||
| MBS7052193-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
NQO1 Antibody |
|||
| MBS7122227-005mg | MyBiosource | 0.05mg | EUR 150 |
NQO1 Antibody |
|||
| MBS7122227-01mg | MyBiosource | 0.1mg | EUR 190 |
NQO1 Antibody |
|||
| MBS7122227-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
NQO1 Antibody |
|||
| MBS9414157-005mL | MyBiosource | 0.05mL | EUR 300 |
NQO1 Antibody |
|||
| MBS9414157-01mL | MyBiosource | 0.1mL | EUR 390 |
NQO1 Antibody |
|||
| MBS9414157-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
NQO1 antibody |
|||
| MBS9409569-01mL | MyBiosource | 0.1mL | EUR 420 |
NQO1 antibody |
|||
| MBS9409569-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
NQO1 Antibody |
|||
| MBS9410499-01mL | MyBiosource | 0.1mL | EUR 420 |
NQO1 Antibody |
|||
| MBS9410499-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
NQO1 Antibody |
|||
| MBS9406145-01mL | MyBiosource | 0.1mL | EUR 305 |
NQO1 Antibody |
|||
| MBS9406145-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
NQO1 Antibody |
|||
| MBS8580525-01mL | MyBiosource | 0.1mL | EUR 305 |
NQO1 Antibody |
|||
| MBS8580525-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
NQO1 Antibody |
|||
| MBS8580525-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
NQO1 Antibody |
|||
| MBS8580525-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
NQO1 Antibody |
|||
| MBS8580525-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
NQO1 Antibody |
|||
| MBS8506043-01mL | MyBiosource | 0.1mL | EUR 325 |
NQO1 Antibody |
|||
| MBS8506043-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
NQO1 Antibody |
|||
| MBS8506043-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
NQO1 Antibody |
|||
| MBS8506043-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
NQO1 Antibody |
|||
| MBS8506043-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
NQO1 Antibody |
|||
| MBS2528040-006mL | MyBiosource | 0.06mL | EUR 190 |
NQO1 Antibody |
|||
| MBS2528040-012mL | MyBiosource | 0.12mL | EUR 265 |
NQO1 Antibody |
|||
| MBS2528040-02mL | MyBiosource | 0.2mL | EUR 415 |
NQO1 Antibody |
|||
| MBS2528040-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
NQO1 Antibody |
|||
| MBS5311755-01mL | MyBiosource | 0.1mL | EUR 1070 |
Collectively, our knowledge counsel that MOSP destined for the TDE OM follows the canonical BAM pathway, whereas formation of a secure periplasmic conformer includes an export-related, folding pathway not current in E. coli.